CAH · Cardinal Health, Inc.
AI read · Neutral
The AI's read
Cardinal posted mixed Q4: EPS $2.91 beat $2.42, while sales missed at $63.672B versus $65.029B. Management raised fiscal 2027 guidance and added $5B to buybacks. Analysts lifted price targets and the stock was up about 1.25% after the print. RSI is 43.74 and price action is muted, so the market looks only partially convinced. The buyback and guidance give upside optionality but the revenue miss caps conviction. We lean neutral until follow-through or clearer sales momentum shows up.